Monopar Therapeutics Ownership | Who Owns Monopar Therapeutics?

Monopar Therapeutics Ownership Summary

Monopar Therapeutics is owned by 59.59% institutional investors, 23.76% insiders, and 16.65% retail investors. Adage capital partners gp is the largest institutional shareholder, holding 9.42% of MNPR shares. iShares Russell 2000 ETF is the top mutual fund, with 1.57% of its assets in Monopar Therapeutics shares.

MNPR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Monopar Therapeutics	59.59%	23.76%	16.65%
Sector	Healthcare Stocks	42.54%	10.83%	46.63%
Industry	Biotech Stocks	45.22%	10.75%	44.04%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Adage capital partners gp	659.20K	9.42%	$53.84M
Ra capital management	511.21K	7.30%	$41.75M
Wellington management group llp	231.46K	3.31%	$18.90M
Vanguard group	208.22K	2.98%	$17.01M
Blackrock funding, inc. /de	203.75K	2.91%	$16.64M
Deerfield management company, l.p. (series c)	159.76K	2.28%	$13.05M
Saturn v capital management	155.37K	2.22%	$12.69M
Tcg crossover management	153.00K	2.19%	$12.50M
Adar1 capital management	130.00K	1.86%	$10.62M
Vivo capital	90.50K	1.29%	$7.39M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Ally bridge group (ny)	64.45K	3.21%	$5.26M
Saturn v capital management	155.37K	2.78%	$12.69M
Adar1 capital management	130.00K	1.00%	$10.62M
Tcg crossover management	153.00K	0.61%	$12.50M
Vivo capital	90.50K	0.59%	$7.39M
Affinity asset advisors	79.48K	0.57%	$6.49M
Ra capital management	511.21K	0.51%	$41.75M
Gerber	5.60K	0.29%	$457.43K
Deerfield management company, l.p. (series c)	159.76K	0.20%	$13.05M
Eam investors	14.63K	0.14%	$1.19M

Top Buyers

Holder	Shares	% Assets	Change
Wellington management group llp	231.46K	0.00%	231.46K
Deerfield management company, l.p. (series c)	159.76K	0.20%	159.76K
Saturn v capital management	155.37K	2.78%	155.37K
Tcg crossover management	153.00K	0.61%	153.00K
Vanguard group	208.22K	0.00%	121.73K

Top Sellers

Holder	Shares	% Assets	Change
Point72 asset management	-	-	-104.02K
Two sigma securities	-	-	-47.06K
Marshall wace, llp	-	-	-25.99K
Ubs group	7.97K	0.00%	-13.90K
Geode capital management	84.96K	0.00%	-11.96K

New Positions

Holder	Shares	% Assets	Change	Value
Wellington management group llp	231.46K	0.00%	231.46K	$18.90M
Deerfield management company, l.p. (series c)	159.76K	0.20%	159.76K	$13.05M
Saturn v capital management	155.37K	2.78%	155.37K	$12.69M
Tcg crossover management	153.00K	0.61%	153.00K	$12.50M
Vivo capital	90.50K	0.59%	90.50K	$7.39M

Sold Out

Holder	Change
Federation des caisses desjardins du quebec	-16.00
Point72 (difc)	-196.00
Raymond james financial	-431.00
Point72 asia (singapore) pte.	-1.76K
Ikarian capital	-5.91K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	51	18.60%	4,170,111	31.28%	59	2.89%	31	-8.82%	15	275.00%
Jun 30, 2025	43	26.47%	3,176,497	10.06%	45	266.08%	34	47.83%	4	-20.00%
Mar 31, 2025	34	88.89%	2,886,019	11.94%	4	8.93%	23	53.33%	5	400.00%
Dec 31, 2024	18	200.00%	2,578,295	16314.94%	6	341848.65%	15	1400.00%	1	-80.00%
Sep 30, 2024	6	-50.00%	15,707	-96.24%	-	16.30%	1	-83.33%	5	400.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
iShares Russell 2000 ETF	96.91K	1.57%	-
Vanguard Institutional Extnd Mkt Idx Tr	45.63K	0.74%	-11.02K
Fidelity Small Cap Index	40.84K	0.66%	40.84K
iShares Russell 2000 Growth ETF	37.34K	0.61%	-
Fidelity Extended Market Index	23.14K	0.38%	-190.00
Vanguard Russell 2000 ETF	19.36K	0.31%	-1.35K
State St Russell Sm Cap® Indx SL Cl I	14.30K	0.23%	-
Schwab Small Cap Index	10.25K	0.17%	-
NT R2000 Index Fund - NL	9.84K	0.16%	9.84K
iShares Micro-Cap ETF	9.22K	0.15%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 24, 2025	Tactic Pharma LLC	-	Sell	$35.00M
Jul 14, 2025	Tsuchimoto Kim R	-	Sell	$356.17K
Jul 14, 2025	STARR CHRISTOPHER M	-	Sell	$672.02K
Jul 14, 2025	Robinson Chandler	Chief Executive Officer	Sell	$672.02K
Apr 02, 2025	Tactic Pharma LLC	-	Sell	$1.17M

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	-	4
2025 Q2	-	1
2025 Q1	-	-
2024 Q4	1	-
2024 Q3	-	-

MNPR Ownership FAQ

Who Owns Monopar Therapeutics?

Monopar Therapeutics shareholders are primarily institutional investors at 59.59%, followed by 23.76% insiders and 16.65% retail investors. The average institutional ownership in Monopar Therapeutics's industry, Biotech Stocks , is 45.22%, which Monopar Therapeutics exceeds.

Who owns the most shares of Monopar Therapeutics?

Monopar Therapeutics’s largest shareholders are Adage capital partners gp (659.2K shares, 9.42%), Ra capital management (511.21K shares, 7.30%), and Wellington management group llp (231.46K shares, 3.31%). Together, they hold 20.03% of Monopar Therapeutics’s total shares outstanding.

Does Blackrock own Monopar Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Monopar Therapeutics.

Who is Monopar Therapeutics’s biggest shareholder by percentage of total assets invested?

Ally bridge group (ny) is Monopar Therapeutics’s biggest shareholder by percentage of total assets invested, with 3.21% of its assets in 64.46K Monopar Therapeutics shares, valued at 5.26M$.

Who is the top mutual fund holder of Monopar Therapeutics shares?

iShares Russell 2000 ETF is the top mutual fund holder of Monopar Therapeutics shares, with 1.57% of its total shares outstanding invested in 96.91K Monopar Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools